Recombinant Human Angiogenin Protein Summary
Product Specifications
Gln25-Pro147
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
265-AN
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
Reconstitution | Reconstitute at 10 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
265-AN/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Assay Procedure
- Recombinant Human Angiogenin (rhAngiogenin) (Catalog # 265-AN)
- Angiogenin Dilution Buffer: PBS, 0.1% BSA
- Standard Curve Buffer: 30 mM HEPES, 0.1% BSA, pH 7.0
- 0.3 M Hepes, 0.3 M NaCl, pH 7.0
- BSA, 0.1% in deionized water
- tRNA, Type X (Sigma, Catalog # R9001), 600 units/mL in Standard Curve Buffer
- RNAse-free water (Ambion cat # AM9920, DEPC treated water)
- Perchloric Acid (Fisher, Catalog # A469-250)
- 96 well clear UV-transparent microplate (Corning, Catalog # 3635)
- UV transparent Spectophotometer cuvette
- Plate Reader (Model: Spectramax Plus by Molecular Devices) or equivalent
- Reconstitute bottled rhAngiogenin to 100 µg/mL with Angiogenin Dilution Buffer.
- Dilute the 100 µg/mL rhAngiogenin to 40, 26.7, 17.8, 11.9, 7.9 and 5.26 µg/mL with Standard Curve Buffer. Include two blank controls.
- Prepare reagent mix using the following volumes for each one tube tested. Prepare at least one extra tube to accommodate volumetric recovery loss (ie. prepare 9x for this protocol: six dilutions and two blanks per lot of rhAngiogenin tested):
0.3 M Hepes, 0.3 M NaCl, pH 7.0 1x=20 µL
0.1% BSA 1x=20 µL
tRNA, 600 units/mL 1x=20 µL
RNAse-free deionized water 1x=90 µL - Combine 150 µL of reagent mix and add 50 µL of each rhAngiogenin dilution to the appropriate tubes. As controls, combine 150 µL of reagent mix with 50 µL of Angiogenin dilution buffer. Mix well.
- Incubate tubes at 37 °C for two hours.
- Dilute perchloric acid to 6% (v/v) in RNAse-free deionized water. Place on ice.
- After incubation, add 200 µL cold 6% perchloric acid to each tube. Mix well and incubate on ice for at least 10 minutes.
- Centrifuge tubes at 2-8 °C at 13,000 rpm for 20 minutes.
- Add 200 µL RNAse-free water to a third set of tubes and place on ice.
- Carefully transfer 100 µL of supernatant from each sample to a tube of RNAse-free water prepared in step 9. Mix well.
- Load 200 µL from each tube into a UV plate. Load reaction blanks, followed by low to high concentrations of rhAngiogenin.
- Fill cuvette with RNAse-free water and place in cuvette port (required for path length correction).
- Read the plate at 260 nm in endpoint mode.
- Plot a linear curve with the amount of rhAngiogenin (µg per well) on the x-axis, and the adjusted Abs260 on the y-axis:
Adjusted Abs260 = [Abssample - Absblank] x 6 (dil. factor) - The rhAngiogenin activity is equal to the slope of the plot ( delta Abs260/µg rhAngiogenin).
- rhAngiogenin: 2.00, 1.330, 0.889, 0.593, 0.395, 0.263, 0 µg
- tRNA: 60 units/mL
Reconstitution Calculator
Background: Angiogenin
Angiogenin was initially purified from serum-free media conditioned by growth of a human adenocarcinoma cell line HT-29 based on its ability to initiate vascularization in the chicken embryo chorioallantoic membrane. A number of other tumor, as well as normal, cell lines can also secrete Angiogenin. In addition, Angiogenin is present in normal human plasma at levels as high as 60-120 ng/mL. Unlike other angiogenic factors such as FGF, Angiogenin is neither mitogenic nor chemotactic for vascular endothelial cells in vitro. However, Angiogenin can stimulate capillary and umbilical vein endothelial cells to produce diacylglycerol and secrete prostacyclin by phospholipase activation. Angiogenin, absorbed on plastic, can also support endothelial and fibroblast cell adhesion and spreading.
Surprisingly, Angiogenin has been found to be a member of the ribonuclease superfamily with approximately 35% sequence similarity at the amino acid level with pancreatic RNase. Angiogenin exhibits ribonucleolytic activity that is distinctly different than that of pancreatic RNase A. The ribonucleolytic activity of Angiogenin toward most RNase A substrates is much lower than that of RNase A. Nevertheless, the ribonucleolytic activity of Angiogenin is essential to its angiogenic activity since inhibition of the Angiogenin RNase activity will also abolish angiogenesis activity. Similar to several members of the RNase superfamily, Angiogenin is a cytotoxic agent that can abolish cellular protein synthesis. It has been demonstrated that Angiogenin-dependent protein synthesis inhibition can be attributed to the function of Angiogenin as a cytotoxic tRNA-specific RNAase.
A cell-surface Angiogenin binding protein has been purified and characterized. Tryptic peptide mapping and sequence analysis indicate that this binding protein is a member of the actin family.
Citations for Recombinant Human Angiogenin Protein
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
11
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Repurposing tRNA isodecoders for non-canonical functions via tRNA cleavage
Authors: Bhatter, N;Advani, VM;Takenaka, Y;Lyons, SM;Akiyama, Y;Anderson, PJ;Ivanov, P;
bioRxiv : the preprint server for biology
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
RTCB Complex Regulates Stress-Induced tRNA Cleavage
Authors: Y Akiyama, Y Takenaka, T Kasahara, T Abe, Y Tomioka, P Ivanov
International Journal of Molecular Sciences, 2022-10-28;23(21):.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Osteoclasts protect bone blood vessels against senescence through the angiogenin/plexin-B2 axis
Authors: X Liu, Y Chai, G Liu, W Su, Q Guo, X Lv, P Gao, B Yu, G Ferbeyre, X Cao, M Wan
Nature Communications, 2021-03-23;12(1):1832.
Species: Mouse
Sample Types: In Vivo
Applications: Bioassay -
Plant-derived angiogenin fusion protein's cytoprotective effect on trabecular meshwork damage induced by Benzalkonium chloride in mice
Authors: JH Jeong, SJ Lee, K Ko, JH Lee, J Lyu, MH Park, J Kang, JC Kim
PeerJ, 2020-05-22;8(0):e9084.
Species: Human
Sample Types: N/A
Applications: Western Blot -
Loss of angiogenin function is related to earlier ALS onset and a paradoxical increase in ALS duration
Authors: KC Aluri, JP Salisbury, JHM Prehn, JN Agar
Sci Rep, 2020-02-28;10(1):3715.
Species: Mouse
Sample Types: In Vivo
Applications: In Vivo -
Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines
Authors: S Rutti, R Dusaulcy, JS Hansen, C Howald, ET Dermitzaki, BK Pedersen, M Pinget, P Plomgaard, K Bouzakri
Sci Rep, 2018-07-03;8(1):10072.
Species: Human, Rat
Sample Types: Whole Cells
Applications: Bioassay -
Pleiotropic activity of systemically delivered angiogenin in the SOD1G93Amouse model
Authors: M Crivello, SL O'Riordan, I Woods, S Cannon, L Halang, KS Coughlan, MC Hogg, SA Lewandowsk, JHM Prehn
Neuropharmacology, 2018-02-25;133(0):503-511.
Species: Mouse
Sample Types: In Vivo
Applications: In Vivo -
Angiogenin-cleaved tRNA halves interact with cytochrome c, protecting cells from apoptosis during osmotic stress.
Authors: Saikia M, Jobava R, Parisien M, Putnam A, Krokowski D, Gao X, Guan B, Yuan Y, Jankowsky E, Feng Z, Hu G, Pusztai-Carey M, Gorla M, Sepuri N, Pan T, Hatzoglou M
Mol Cell Biol, 2014-04-21;34(13):2450-63.
Species: Mouse
Sample Types: Whole Cells
Applications: Bioassay -
Angiogenic sprouting is regulated by endothelial cell expression of Slug.
Authors: Welch-Reardon K, Ehsan S, Wang K, Wu N, Newman A, Romero-Lopez M, Fong A, George S, Edwards R, Hughes C
J Cell Sci, 2014-02-19;127(0):2017-28.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
The hedgehog system in ovarian follicles of cattle selected for twin ovulations and births: evidence of a link between the IGF and hedgehog systems.
Authors: Aad, Pauline, Echternkamp, Sherrill, Sypherd, David D, Schreiber, Nicole B, Spicer, Leon J
Biol Reprod, 2012-10-04;87(4):79.
Species: Bovine
Sample Types: Whole Cells
Applications: Bioassay -
ACTIBIND, a T2 RNase, competes with angiogenin and inhibits human melanoma growth, angiogenesis, and metastasis.
Authors: Schwartz B, Shoseyov O, Melnikova VO, McCarty M, Leslie M, Roiz L, Smirnoff P, Hu GF, Lev D, Bar-Eli M
Cancer Res., 2007-06-01;67(11):5258-66.
Species: Mouse
Sample Types: In Vivo
Applications: In Vivo
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human Angiogenin Protein
There are currently no reviews for this product. Be the first to review Recombinant Human Angiogenin Protein and earn rewards!
Have you used Recombinant Human Angiogenin Protein?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image